课题基金 / 基金详情

Pharmacokinetic/Pharmacodynamic model in pregnant women with depression to guide sertraline dosing

Pharmacokinetic/Pharmacodynamic model in pregnant women with depression to guide sertraline dosing
抑郁症孕妇的药代动力学/药效学模型指导舍曲林给药
批准号:
10390578
负责人:
ANGELA K BIRNBAUM
金额:
$22.35万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-08-18 至 2024-07-31

项目摘要

项目成果

ANGELA K BIRNBAUM的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Abstract Depression and anxiety during pregnancy affect over 10% of women with 6-8% of pregnant women receiving a prescription for a selective serotonin reuptake inhibitor (SSRI) antidepressant. Sertraline is the most commonly prescribed SSRI in women of reproductive years. However, there remains limited information for optimizing its treatment during pregnancy. Sertraline shows large inter-individual variability although studies generally suffer from small sample sizes and inconsistent observations. Physiological changes accompanying pregnancy can alter drug pharmacokinetics (e.g., clearance) which can significantly affect steady-state concentrations of medications, supporting the need for dose adjustments in order to maintain pre-pregnancy drug exposure. Our objective is to quantify the contribution of sertraline pharmacokinetic exposure to maternal health and obstetrical/neonatal outcomes. The Women’s Mental Health Program database contains prospectively collected data from more than 2,500 individuals with neuropsychiatric illnesses across more than 15,000 unique visits during the perinatal and postpartum periods. Sertraline and metabolite concentrations along with maternal symptoms and obstetrical/neonatal outcome information will be analyzed via pharmacokinetic/pharmacodynamic modeling enabling characterization of the relationships between changes in sertraline exposure with maternal symptoms of depression and neonatal outcomes during pregnancy and postpartum. Results from this project will support refinement of dosing strategies and evidence-based personalized treatment planning for the use of sertraline during pregnancy. The application of pharmacokinetic- guided dosing will result in enhanced prevention of disease-related symptoms and improved maternal and child health. This project will provide the foundation for investigation of other antidepressants and psychotropic medications used during pregnancy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pharmacokinetic/Pharmacodynamic model in pregnant women with depression to guide sertraline dosing
  • 批准号:
    10685934
  • 项目类别:
  • 资助金额:
    $18.92万
  • 财政年份:
    2022
  • 负责人:
    ANGELA K BIRNBAUM
  • 依托单位:
Physiological-based Pharmacokinetics Approach to Determine the Extent of Drug Exposure of Antiseizure Medications During Pregnancy and Breastfeeding
  • 批准号:
    10461805
  • 项目类别:
  • 资助金额:
    $55.04万
  • 财政年份:
    2021
  • 负责人:
    ANGELA K BIRNBAUM
  • 依托单位:
Clinical Impact of Unstable AED Levels in Elderly Nursing Home Epilepsy Patients
  • 批准号:
    7319735
  • 项目类别:
  • 资助金额:
    $34.48万
  • 财政年份:
    2007
  • 负责人:
    ANGELA K BIRNBAUM
  • 依托单位:
Clinical Impact of Unstable AED Levels in Elderly Nursing Home Epilepsy Patients
  • 批准号:
    7676030
  • 项目类别:
  • 资助金额:
    $38.81万
  • 财政年份:
    2007
  • 负责人:
    ANGELA K BIRNBAUM
  • 依托单位:
海外基金